167 related articles for article (PubMed ID: 34503108)
1. Glioma genetic profiles associated with electrophysiologic hyperexcitability.
Tobochnik S; Dorotan MKC; Ghosh HS; Lapinskas E; Vogelzang J; Reardon DA; Ligon KL; Bi WL; Smirnakis SM; Lee JW
Neuro Oncol; 2024 Feb; 26(2):323-334. PubMed ID: 37713468
[TBL] [Abstract][Full Text] [Related]
2. Concurrent
El-Ayadi M; Egervari K; Merkler D; McKee TA; Gumy-Pause F; Stichel D; Capper D; Pietsch T; Ansari M; von Bueren AO
Front Neurol; 2018; 9():398. PubMed ID: 29971034
[TBL] [Abstract][Full Text] [Related]
3. Integration of Multi-Omics Data for the Classification of Glioma Types and Identification of Novel Biomarkers.
Vieira FG; Bispo R; Lopes MB
Bioinform Biol Insights; 2024; 18():11779322241249563. PubMed ID: 38812741
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Molecular Genetic Analysis in Glioma Patients by Next Generation Sequencing.
Kim T; Lee A; Ahn S; Park JS; Jeun SS; Lee YS
Brain Tumor Res Treat; 2024 Jan; 12(1):23-39. PubMed ID: 38317486
[TBL] [Abstract][Full Text] [Related]
5. IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients.
Crucitta S; Pasqualetti F; Gonnelli A; Ruglioni M; Luculli GI; Cantarella M; Ortenzi V; Scatena C; Paiar F; Naccarato AG; Danesi R; Del Re M
BMC Cancer; 2024 Jan; 24(1):31. PubMed ID: 38172718
[TBL] [Abstract][Full Text] [Related]
6. Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
Nassani R; Bokhari Y; Alrfaei BM
PLoS One; 2023; 18(11):e0287448. PubMed ID: 37972206
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Characterization of Copper-Binding Proteins for Predicting Prognosis in Glioma.
Zeng HL; Li H; Yang Q; Li CX
Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891828
[TBL] [Abstract][Full Text] [Related]
8. Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials.
Sharma N; Mallela AN; Shi DD; Tang LW; Abou-Al-Shaar H; Gersey ZC; Zhang X; McBrayer SK; Abdullah KG
Neurooncol Adv; 2023; 5(1):vdad053. PubMed ID: 37287696
[TBL] [Abstract][Full Text] [Related]
9. Recognition of Differentially Expressed Molecular Signatures and Pathways Associated with COVID-19 Poor Prognosis in Glioblastoma Patients.
Alzahrani FA; Khan MF; Ahmad V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834974
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.
Liu HQ; Li WX; An YW; Wu T; Jiang GY; Dong Y; Chen WX; Wang JC; Wang C; Song S
Int J Immunopathol Pharmacol; 2022; 36():3946320221139262. PubMed ID: 36377597
[No Abstract] [Full Text] [Related]
11. Ambra1 in cancer: implications for clinical oncology.
Qin YQ; Liu SY; Lv ML; Sun WL
Apoptosis; 2022 Oct; 27(9-10):720-729. PubMed ID: 35994214
[TBL] [Abstract][Full Text] [Related]
12. Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas.
Cabezas-Camarero S; García-Barberán V; Pérez-Alfayate R; Casado-Fariñas I; Sloane H; Jones FS; Pérez-Segura P
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740557
[TBL] [Abstract][Full Text] [Related]
13. Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma.
Everix L; Nair S; Driver CHS; Goethals I; Sathekge MM; Ebenhan T; Vandevoorde C; Bolcaen J
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406593
[TBL] [Abstract][Full Text] [Related]
14. Odorant receptors in cancer.
Chung C; Cho HJ; Lee C; Koo J
BMB Rep; 2022 Feb; 55(2):72-80. PubMed ID: 35168702
[TBL] [Abstract][Full Text] [Related]
15. Arginine Depletion in Human Cancers.
Nelakurti DD; Rossetti T; Husbands AY; Petreaca RC
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944895
[TBL] [Abstract][Full Text] [Related]
16. Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas: a systematic analysis and review.
Cho HJ; Koo J
BMB Rep; 2021 Dec; 54(12):601-607. PubMed ID: 34847986
[TBL] [Abstract][Full Text] [Related]
17. A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database.
Pappula AL; Rasheed S; Mirzaei G; Petreaca RC; Bouley RA
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503108
[TBL] [Abstract][Full Text] [Related]
18. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic Landscape of Lower Grade Glioma Based on Age-Related Non-Silent Somatic Mutations.
Park Y; Park J; Ahn JW; Sim JM; Kang SJ; Kim S; Hwang SJ; Han SH; Sung KS; Lim J
Curr Oncol; 2021 Jun; 28(3):2281-2295. PubMed ID: 34205437
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
